Extraocular Muscle Atrophy and Central Nervous System Involvement in Chronic Progressive External Ophthalmoplegia

• Published in: PloS one Vol. 8; no. 9; p. e75048
• Main Authors: Yu-Wai-Man, Cynthia, Smith, Fiona E., Firbank, Michael J., Guthrie, Grant, Guthrie, Stuart, Gorman, Grainne S., Taylor, Robert W., Turnbull, Douglass M., Griffiths, Philip G., Blamire, Andrew M., Chinnery, Patrick F., Yu-Wai-Man, Patrick
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 27.09.2013; Public Library of Science (PLoS)
• Subjects: Adult; Aged; Atrophy; Brain; Brain - metabolism; Brain - pathology; Brain stem; Case-Control Studies; Cell Compartmentation; Central nervous system; Central Nervous System - pathology; Cerebellum; Cohort Studies; Control methods; Cortex; Deoxyribonucleic acid; DNA; DNA, Mitochondrial - genetics; Eye; Eye - pathology; Eye movements; Female; Humans; Magnetic resonance; Magnetic resonance imaging; Magnetic resonance spectroscopy; Male; Metabolites; Metabolome; Middle Aged; Mitochondrial DNA; Muscles; Muscular Atrophy - pathology; Mutation; Neuroimaging; Neurological diseases; NMR; Nuclear magnetic resonance; Ophthalmoplegia; Ophthalmoplegia, Chronic Progressive External - genetics; Ophthalmoplegia, Chronic Progressive External - pathology; Orbital resonances (celestial mechanics); Organ Size; Patients; Proton magnetic resonance; Resonance; Sequence Deletion; Spectroscopy; Spectrum analysis; Subgroups; Substantia alba; United Kingdom > UK
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0075048

Chronic progressive external ophthalmoplegia (CPEO) is a classical mitochondrial ocular disorder characterised by bilateral progressive ptosis and ophthalmoplegia. These ocular features can develop either in isolation or in association with other prominent neurological deficits (CPEO+). Molecularly, CPEO can be classified into two distinct genetic subgroups depending on whether patients harbour single, large-scale mitochondrial DNA (mtDNA) deletions or multiple mtDNA deletions secondary to a nuclear mutation disrupting mtDNA replication or repair. The aim of this magnetic resonance imaging (MRI) study was to investigate whether the ophthalmoplegia in CPEO is primarily myopathic in origin or whether there is evidence of contributory supranuclear pathway dysfunction. Ten age-matched normal controls and twenty patients with CPEO were recruited nine patients with single, large-scale mtDNA deletions and eleven patients with multiple mtDNA deletions secondary to mutations in POLG, PEO1, OPA1, and RRM2B. All subjects underwent a standardised brain and orbital MRI protocol, together with proton magnetic resonance spectroscopy in two voxels located within the parietal white matter and the brainstem. There was evidence of significant extraocular muscle atrophy in patients with single or multiple mtDNA deletions compared with controls. There was no significant difference in metabolite concentrations between the patient and control groups in both the parietal white matter and brainstem voxels. Volumetric brain measurements revealed marked cortical and cerebellar atrophy among patients with CPEO+ phenotypes. The results of this study support a primary myopathic aetiology for the progressive limitation of eye movements that develops in CPEO.